Hangzhou AGS MedTech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	597.21	632.86	506.09	368.92	305.1
Other Revenue	-	3.78	2.65	2.2	0.37
Revenue	597.21	636.63	508.75	371.11	305.47
Revenue Growth (YoY)	-6.19%	25.14%	37.09%	21.49%	77.64%
Cost of Revenue	-	180.84	149.86	119.38	108.54
Gross Profit	597.21	455.79	358.89	251.73	196.92
Selling, General & Admin	-	108.89	95.38	66.59	53
Research & Development	-	59.21	41.25	31.46	24.19
Other Operating Expenses	332.38	6.09	1.39	3.29	2.43
Operating Expenses	332.38	173.69	140.17	101.63	79.83
Operating Income	264.82	282.11	218.72	150.1	117.09
Interest & Investment Income	-	55.23	28.91	2.59	2.52
Currency Exchange Gain (Loss)	-	0.32	0.69	11.1	-4.24
Other Non Operating Income (Expenses)	-0.9	1.19	-1.05	-0.84	-0.14
EBT Excluding Unusual Items	263.92	338.85	247.28	162.95	115.23
Gain (Loss) on Sale of Investments	-	2.08	0.41	-7.19	1.09
Gain (Loss) on Sale of Assets	-	-0.19	-0.35	-0.14	-0.01
Asset Writedown	-	-0.02	-0.46	-0	-0.14
Other Unusual Items	-	2.87	4.78	9.94	3.79
Pretax Income	263.92	343.6	251.67	165.56	119.97
Income Tax Expense	41.1	50.21	34.43	20.6	15.17
Net Income	222.82	293.39	217.24	144.96	104.8
Net Income to Common	222.82	293.39	217.24	144.96	104.8
Net Income Growth	-24.05%	35.06%	49.86%	38.32%	131.68%
Shares Outstanding (Basic)	80	81	73	61	61
Shares Outstanding (Diluted)	80	81	73	61	61
Shares Change (YoY)	-0.18%	11.02%	19.46%	-	-
EPS (Basic)	2.77	3.64	2.99	2.39	1.72
EPS (Diluted)	2.77	3.64	2.99	2.39	1.72
EPS Growth	-23.92%	21.65%	25.44%	38.60%	131.71%
Free Cash Flow	-	266.19	169.88	96.26	102.59
Free Cash Flow Per Share	-	3.30	2.34	1.58	1.69
Dividend Per Share	-	1.373	1.036	0.543	-
Dividend Growth	-	32.62%	90.77%	-	-
Gross Margin	100.00%	71.59%	70.54%	67.83%	64.47%
Operating Margin	44.34%	44.31%	42.99%	40.45%	38.33%
Profit Margin	37.31%	46.09%	42.70%	39.06%	34.31%
Free Cash Flow Margin	-	41.81%	33.39%	25.94%	33.59%
EBITDA	272.79	290.07	225.29	154.82	121.17
EBITDA Margin	45.68%	45.56%	44.28%	41.72%	39.67%
D&A For EBITDA	7.96	7.96	6.56	4.72	4.07
EBIT	264.82	282.11	218.72	150.1	117.09
EBIT Margin	44.34%	44.31%	42.99%	40.45%	38.33%
Effective Tax Rate	15.57%	14.61%	13.68%	12.44%	12.64%
Revenue as Reported	-	636.63	508.75	371.11	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.